Role of Bioinformatics in Identifying Novel Biomarkers for Immune Cell Exhaustion and Tumor Microenvironment
Technology in Cancer Research & Treatment · 2026-04 · 25
DOI: 10.1177/15330338261441019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 01.04.2026. Verfasst von Yanxia Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Computational Biology, Biomarkers, Tumor, Neoplasms. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Zhejiang Province Medical and Health Science and Technology Project.
Abstract (Originalsprache)
This review explores the role of bioinformatics in identifying novel biomarkers for immune cell exhaustion (ICE), a dysfunction state in T cells during chronic infections and cancer. ICE, marked by upregulation of inhibitory receptors such as PD-1 and CTLA-4, impairs immune responses, a critical barrier in chronic infection and cancer treatment. Understanding this state is crucial for developing therapies to reverse T cell exhaustion and improve immune function. The review highlights advanced bioinformatics tools that analyze high-throughput sequencing data, transcriptomics, proteomics, and metabolomics to identify biomarkers and therapeutic targets, enhancing diagnostics and treatments. Despite challenges like the complexity and heterogeneity of ICE, the integration of bioinformatics has advanced our molecular understanding and identification of key pathways. This facilitates the development of personalized immunotherapies, improving outcomes for patients with chronic infections and cancer. Additionally, this review emphasizes the tumor microenvironment’s (TME) role in ICE, where factors such as the upregulation of immune checkpoint ligands, secretion of immunosuppressive cytokines like Transforming Growth Factor Beta (TGF-β) and Interleukin 10 (IL-10), and recruitment of regulatory immune cells create an immunosuppressive milieu fostering tumor growth. In conclusion, this review will also discuss the future directions for research in biomarker discovery and the integration of bioinformatics with clinical data to enhance the precision and effectiveness of therapies. By addressing these challenges, future research can lead to more targeted and efficient treatments for patients suffering from chronic infections and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
- Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou, China.
ORCID-Profile: Yinying Chai, Yibo He, Wenyu Cai
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Province Medical and Health Science and Technology Project
Zitieren
APA
Huang, Y., Ding, H., Chai, Y., Ding, Y., Chi, J., Ying, J., Bian, X., He, Y., & Cai, W. (2026). Role of Bioinformatics in Identifying Novel Biomarkers for Immune Cell Exhaustion and Tumor Microenvironment. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261441019
Vancouver
Huang Y, Ding H, Chai Y, Ding Y, Chi J, Ying J, et al. Role of Bioinformatics in Identifying Novel Biomarkers for Immune Cell Exhaustion and Tumor Microenvironment. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261441019
BibTeX
@article{Huang2026,
author = {Huang, Yanxia and Ding, Huizhe and Chai, Yinying and Ding, Yun and Chi, Jiajia and Ying, Jiajia and Bian, Xuemei and He, Yibo and Cai, Wenyu},
title = {Role of Bioinformatics in Identifying Novel Biomarkers for Immune Cell Exhaustion and Tumor Microenvironment},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
volume = {25},
doi = {10.1177/15330338261441019}
}
EUVIMED